Outsourcing-Pharma.com presents its periodic round-up of personnel changes in the pharmaceutical outsourcing arena, with senior appointments at Bristol-Myers Squibb, Parexel and GVK Bio, amongst others.
Pharmaceutical companies in the developed world have already
shifted substantial manufacturing and clinical trial work to
emerging economies such as China and India, but a new study suggest
they are increasingly counting on these...
Pfizer has enlisted outsourcing services firm NovaMed
Pharmaceuticals to conduct the distribution, sales and marketing of
some of its products in the country.
The US Food and Drug Administration (FDA) has sent Merck & Co a
warning letter saying it has failed to correct a number of
manufacturing deficiencies at its main vaccine manufacturing plant
in West Point, Pennsylvania.
Overall, 2007 was another stellar year for contract service
providers, particularly those at the early-stage end of
development, although companies are advised to watch out for a
tougher environment ahead.
United Drug has just purchased two UK services firms for a sum of
£14.4m, in a continuation of what has been a highly-acquisitive
past year for the ambitious firm.
1200 sales representatives are the latest casualties of Wyeth's
recently announced cost cutting drive, which strives to eliminate
10 per cent of the work force - 5,000 jobs - over the next three
years.
After losing a key Novartis contract and getting caught up in the
Inyx collapse, Inventiv Health had good news this week when it
reported its third quarter results.
Californian marketing company BlueLithium has launched a new
web-based solution to help pharma companies overcome the challenges
of recruiting patients for clinical trials.
In a round-up of motley pharmaceutical services news,
Outsourcing-Pharma takes a look at recent announcements involving
Quintiles, Kenexa, Atos, Catalent Pharma, Patni and Taratec.
Quintiles' subsidiary Pharmalink has acquired the marketing rights
to Eli Lilly India's flagship antibiotic brand Distaclor (cefaclor)
in a bid to boost its core services business.
Two of the UK's top contract sales organisations (CSO) have merged
to create what is claimed to be the country's leading CSO -
something that is disputed by its nearest rival.
In a round-up of motley pharmaceutical services contracts,
Outsourcing-Pharma takes a look at recent news involving Movianto,
PDI, inVentiv Health and Exel.
The pharmaceutical and healthcare industries will help to push
trade between India and the United Kingdom up by 60 per cent within
three years, claims a soon-to-be released report.
GlaxoSmithKline (GSK) has decided to consolidate all its human
resources business process outsourcing (BPO) services under the one
umbrella in a contract valued at $171m (€131m).
Parexel has announced encouraging financial results for its second
fiscal quarter, despite 'disappointing' performance in its medical
communications business.
More companies in the pharmaceutical industry than any other
industry are set to increase their reliance on information
technology (IT) and business process (BP) outsourcing this year,
new research indicates.
India is the first choice for foreign companies looking to offshore
their knowledge process outsourcing (KPO) activities and future
growth will be fuelled by the pharma market, according to a new
report.
The contract sales and marketing business will reach $5.2bn (€4bn)
by 2011, as it represents an ideal outsourcing opportunity for
pharma companies competing in this fast growing sector, according
to new market research.
Pharmaceutical companies are beginning to catch up with other
industry sectors that take an increasingly realistic view of what
they consider a core competency and outsourcing what is left -
Outsourcing-Pharma takes a snapshot of...
Pharma companies that aren't maximising their outsourcing potential
in clinical research may be wasting a world of opportunity.
OutsourcingPharma.com gives a brief run down of exactly what kinds
of services and providers are...
GlaxoSmithKline (GSK) has told contract sales organisation (CSO)
PDI that it will not renew its sales contract with the firm at the
end of the year, signalling a devastating $65m-$70m loss in annual
revenue for the struggling firm.
As financial pressures continue to plague the pharma industry,
firms should consider taking more advantage of sourcing staff in
cheap labour markets in order to save a buck.
Troubled contract sales and marketing firm PDI has recently won a
much-needed new sales contract and made two new top executive
appointments as part of ongoing efforts to turn its flagging
business around.
After three acquisitions in two months, inVentiv Health has now
expanded capacity in two of its divisions to meet the needs of its
jump in client base.
inVentiv Health (Formerly Ventiv Health) saw its fourth quarter
profits dive in 2005 by 37 per cent after being hit by higher
interest expenses and an income tax provision, however, the company
managed to increase its sales for the...
The Pharmaceutical Institute, provider of specialised knowledge for
the pharma industry, is now providing custom research services to
cater for those with complex research needs.
Ventiv Health has spent the last month buying up companies. After
buying Aheris in February, the company has since agreed to acquire
US clinical services provider Synergos, as well as Canadian
healthcare marketing and communications...
With a 30 per cent grip on the $100m (€84m) global customer
relationship management (CRM) market from its dealings in the US,
C3i is now taking on Europe - a market that holds similar potential
to the US - and finding little competition...
AstraZeneca has pulled the plug on a long-running service contract
with PDI, adding another blow to the company who last week reported
a dive from profit to loss in 2005, with a net loss of nearly $20m
(€16m), versus net income of...
Chiltern is expanding its clinical trial services business in
India, and in doing so will be the first company to provide
specialised staff recruitment services for the Indian clinical
research industry.
Ventiv, which conducts clinical, sales, marketing and
communications services for the pharma industry, has added a new
arm to its business after agreeing to buy Adheris, a leading
provider of patient adherence programs.
Emerging biopharmaceutical company, Align Pharmaceuticals, has
enlisted sales and marketing services provider, PDI, to provide a
40-person sales force for its three newly acquired oncology
products.
Porter Novelli, one of the world's leading public relations
agencies, has acquired Californian life sciences agency, Atkins +
Associates, in a move to establish a new business unit that will
serve as the first corporate and marketing...
UK's In2Focus Healthcare Technologies has formed a strategic
alliance with Canadian based IsaiX Technologies, to co-promote each
other's IT technology services for the pharma industry in Europe
and North America.
PDI, who provides sales and marketing services to the
pharmaceutical industry, have received a new sales representative
contract in the US from GlaxoSmithKline (GSK), worth $65-70m
(€55-59m).
Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...
